Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis

Affiliations

• ¹ Department of Radiological, Oncological and Pathological Sciences, Sapienza University, 00161, Rome, Italy.
• ² Department of Experimental Medicine, Sapienza University, 00161, Rome, Italy. daniele.marinelli@uniroma1.it.
• ³ Department of Oral Sciences and Maxillofacial Surgery, Sapienza University, 00161, Rome, Italy.
• ⁴ Department of Sense Organs, Sapienza University, 00161, Rome, Italy.
• ⁵ Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University, 04100, Latina, Italy.
• ⁶ Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25121, Brescia, Italy.
• ⁷ Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), 00167, Rome, Italy.